APOBEC3G and G-to-A hypermutation in Asian children with different HIV/AIDS disease progression

APOBEC3G and G-to-A hypermutation in Asian children with different HIV/AIDS disease progression

Bibliographic Details
Main Authors:	T. Bunupuradah, K. Matsuoka, M. Imahashi, Y. Iwatani, J. Ananworanich, T. Yagi, L. Aurpibul, T. Puthanakit, P. Phanuphak, S. Vonthanak, W. Sugiura
Format:	Article
Language:	English
Published:	Elsevier 2014-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971214010923

Similar Items

Association of <it>APOBEC3G</it> genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency
by: Bunupuradah Torsak, et al.
Published: (2012-11-01)

APOBEC3G-mediated G-to-A hypermutation of the HIV-1 genome: the missing link in antiviral molecular mechanisms
by: Ayaka Okada, et al.
Published: (2016-12-01)

Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation.
by: Krista A Delviks-Frankenberry, et al.
Published: (2016-05-01)

Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
by: Nívea D Amoêdo, et al.
Published: (2011-01-01)

HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G.
by: Terumasa Ikeda, et al.
Published: (2018-04-01)

The roles of APOBEC3G complexes in the incorporation of APOBEC3G into HIV-1.
by: Jing Ma, et al.
Published: (2013-01-01)

Antiviral Mechanism and biochemical basis of the human APOBEC3 family
by: Mayumi eImahashi, et al.
Published: (2012-07-01)

APOBEC3G levels predict rates of progression to AIDS
by: Wu Hulin, et al.
Published: (2007-03-01)

APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon
by: Armitage, A, et al.
Published: (2012)

APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.
by: Andrew E Armitage, et al.
Published: (2012-01-01)

APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome
by: Ebrahimi Diako, et al.
Published: (2012-12-01)

Double-Dose Hepatitis B Revaccination in Nonresponsive HIV-Infected Adolescents
by: Torsak Bunupuradah MD, et al.
Published: (2013-05-01)

Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization
by: Walker Robert C, et al.
Published: (2009-11-01)

The cellular source for APOBEC3G's incorporation into HIV-1
by: Guo Fei, et al.
Published: (2011-01-01)

Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
by: Armitage, A, et al.
Published: (2008)

Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
by: Kouichi Kitamura, et al.
Published: (2013-01-01)

Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk.
by: Mayumi Imahashi, et al.
Published: (2014-01-01)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
by: Kousho Wakae, et al.
Published: (2020-10-01)

Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
by: Friew Yeshitila N, et al.
Published: (2009-06-01)

APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.
by: Russell, R, et al.
Published: (2009)

APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA
by: Pathak Vinay K, et al.
Published: (2009-02-01)

Retraction: the cellular source for APOBEC3G's incorporation into HIV-1
by: Ma Jing, et al.
Published: (2011-11-01)

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.
by: Kate N Bishop, et al.
Published: (2008-12-01)

APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
by: Khan Mohammad A, et al.
Published: (2008-07-01)

Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
by: Armitage, A, et al.
Published: (2014)

Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
by: Benjamin Stupfler, et al.
Published: (2021-04-01)

Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
by: Michael Letko, et al.
Published: (2015-12-01)

HIV-1 Vif and APOBEC3G: Multiple roads to one goal
by: Goncalves Joao, et al.
Published: (2004-09-01)

RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
by: Hendrik Huthoff, et al.
Published: (2009-03-01)

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
by: Tavitiya Sudjaritruk, et al.
Published: (2019-01-01)

Model structure of human APOBEC3G.
by: Kun-Lin Zhang, et al.
Published: (2007-04-01)

Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
by: Jern, P, et al.
Published: (2009)

Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
by: Patric Jern, et al.
Published: (2009-04-01)

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
by: Yunjie Duan, et al.
Published: (2022-10-01)

The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques.
by: Yufei Wang, et al.
Published: (2012-01-01)

Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G.
by: David J Stanley, et al.
Published: (2012-12-01)

APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.
by: Tegwinde Rebeca Compaore, et al.
Published: (2016-01-01)

Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G In Vivo
by: Stavrou, Spyridon, et al.
Published: (2014)

Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
by: Eric W Refsland, et al.
Published: (2012-01-01)

Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents
by: T. Bunupuradah, et al.
Published: (2014-04-01)